First anti-Covid-19 drug endorsed by EU regulator

The European Medicines Agency (EMA), the EU’s healthcare regulator, endorsed the anti-viral drug Remdesivir as a treatment for Covid-19, putting it on track to be used in EU countries, news wires reported. The EMA said it had recommended the drug for use in adults and adolescents from 12 years of age with pneumonia who require oxygen support.

Remdesivir, which has been used against Ebola, is currently undergoing clinical trials around the world to better understand its effects. UK regulators approved the drug for use in selected Covid-19 hospital patients at the end of May, the BBC reported.

Remdesivir will need final approval from the European Commission before it can be prescribed in EU countries.

More on this subject: Coronavirus

Similar articles